Cancer-Type Organic Anion Transporting Polypeptide 1B3: Current Knowledge of the Gene Structure, Expression Profile, Functional Implications and Future Perspectives

Author(s): Tomomi Furihata, Yuchen Sun, Kan Chiba

Journal Name: Current Drug Metabolism

Volume 16 , Issue 6 , 2015

Become EABM
Become Reviewer
Call for Editor


Human organic anion transporting polypeptide 1B3 (OATP1B3) is a hepatocyte drug transporter that facilitates uptake of various therapeutic drugs from the circulatory system. Shortly after its initial identification in the liver, OATP1B3 expression was also reported in various solid cancer tissues. In the years since that time, it has been presumed that the OATP1B3 expressed in cancer tissues is identical to that expressed in the liver. However, we have recently identified a new OATP1B3 mRNA variant in cancer tissues, which we have named cancer-type OATP1B3 (Ct-OATP1B3). Given that the identification of Ct-OAT1B3 as a bona fide cancer-associated isoform revises a longstanding study premise, it is essential to fully elucidate the molecular function of Ct-OATP1B3 in cancer cells. Based on the predicted Ct-OATP1B3 protein structure, it is reasonable to assume that it functions as a transporter, but there are a number of ongoing arguments regarding Ct-OATP1B3 protein expression and its functions. With the above points in mind, this review will summarize current knowledge of Ct-OATP1B3 mRNA expression features in cancer tissues and its proposed, yet currently controversial, functions. Based on that background, our future perspectives related to Ct-OATP1B3 studies will also be presented.

Keywords: Cancer, cancer biomarker, cancer-specific molecule, OATP1B3, SLCO1B3, splice variant, transporter.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2015
Published on: 07 October, 2015
Page: [474 - 485]
Pages: 12
DOI: 10.2174/1389200216666150812142715
Price: $65

Article Metrics

PDF: 81
PRC: 1